In vivo human time-exposure study of orally dosed commercial silver nanoparticles.
about
Nanoparticles: Alternatives Against Drug-Resistant Pathogenic MicrobesMechanistic Basis of Antimicrobial Actions of Silver NanoparticlesImpact of pulmonary exposure to gold core silver nanoparticles of different size and capping agents on cardiovascular injuryPotential applications and human biosafety of nanomaterials used in nanomedicineAntimicrobial activity of bone cements embedded with organic nanoparticlesGreen synthesis of silver nanoparticles via plant extracts: beginning a new era in cancer theranostics.Effects of particle size and coating on toxicologic parameters, fecal elimination kinetics and tissue distribution of acutely ingested silver nanoparticles in a mouse model.Differential Effects of Silver Nanoparticles and Silver Ions on Tissue Accumulation, Distribution, and Toxicity in the Sprague Dawley Rat Following Daily Oral Gavage Administration for 13 WeeksHow nanotechnology-enabled concepts could contribute to the prevention, diagnosis and therapy of bacterial infections.Responses of human hepatoma HepG2 cells to silver nanoparticles and polycyclic aromatic hydrocarbons.Silver nanoparticles protect human keratinocytes against UVB radiation-induced DNA damage and apoptosis: potential for prevention of skin carcinogenesis.Mucus and microbiota as emerging players in gut nanotoxicology: The example of dietary silver and titanium dioxide nanoparticles.Preclinical safety assessments of nano-sized constructs on cardiovascular system toxicity: A case for telemetry.Assessing orally bioavailable commercial silver nanoparticle product on human cytochrome P450 enzyme activity.The silver lining: towards the responsible and limited usage of silver.Strong and Nonspecific Synergistic Antibacterial Efficiency of Antibiotics Combined with Silver Nanoparticles at Very Low Concentrations Showing No Cytotoxic Effect.Differential effects of silver nanoparticles on DNA damage and DNA repair gene expression in Ogg1-deficient and wild type mice.Oral subchronic exposure to silver nanoparticles causes renal damage through apoptotic impairment and necrotic cell death.From the Cover: Comparative Proteomics Reveals Silver Nanoparticles Alter Fatty Acid Metabolism and Amyloid Beta Clearance for Neuronal Apoptosis in a Triple Cell Coculture Model of the Blood-Brain Barrier.Biosynthesized silver nanoparticles: a step forward for cancer theranostics?Assessment of the migration potential of nanosilver from nanoparticle-coated low-density polyethylene food packaging into food simulants.The stability of citrate-capped silver nanoparticles in isotonic glucose solution for intravenous injection.Impact of food components during in vitro digestion of silver nanoparticles on cellular uptake and cytotoxicity in intestinal cells.Silver Nanoparticles: Synthetic Routes, In Vitro Toxicity and Theranostic Applications for Cancer Disease.Nano-Strategies to Fight Multidrug Resistant Bacteria-"A Battle of the Titans"
P2860
Q26746108-208AB7C3-3BB8-4ACF-9D04-5DDCA80CF319Q28079834-5D995F93-59F0-4C9D-8838-D41129900BDBQ28387533-581C6299-057D-4FD6-BEC1-3CB5F7543EF7Q32944368-270C5F85-9D85-4A6B-9BD0-E22D4CFD4AA1Q36165412-D9CE1E84-C8F4-4EF8-A32A-B2182C80E8B6Q36181235-04D05B58-3B1B-466A-BED2-C414DE4EA88BQ36619973-40D218DD-9D50-4810-97A4-EAD806D264EAQ37228586-B5B2597D-F296-47F1-85A3-D575208AC15CQ38507930-4871367D-B33F-47D2-A1D1-2B3B10810FDDQ38672832-E187643A-90B6-48C2-AA0B-93358CA652B3Q38895698-73ACB02D-C138-4D7C-A624-9F4B259F5969Q38980467-B7EF29B3-61EB-4526-8487-A43C08EBA212Q39121977-7A6752A8-81DA-4615-A701-93EDA252BBFDQ39142964-6E2E8518-2CA1-4E80-A930-2275209180C1Q39398372-4D0C222F-BD98-43D6-90B0-DDADD5C5B46FQ42815902-05310B82-53DD-4927-A496-9980A2E24288Q47432231-3B7EA09B-8263-4003-B00E-2F630D3BA6C8Q47729007-6934EC37-37B7-4217-B26B-C5ECD1CBCE71Q50894478-AB02C90D-4433-4B2B-9337-9421F6CC4676Q51050638-7B222B43-587D-45D8-A94A-15B9054A84D2Q51663061-69C015C0-0CD4-4434-8034-0FA07CDBA0F7Q53306441-98EEE4F5-8D4D-44BF-9591-57506F9437C4Q53480655-1B9EB5CD-ECA2-4349-8282-6CD280B4FEB3Q55067507-DEA83DE1-94E0-4760-B740-1476041C62F6Q57177419-8E707C6F-9589-4C82-97C0-7301E388B987
P2860
In vivo human time-exposure study of orally dosed commercial silver nanoparticles.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vivo human time-exposure study of orally dosed commercial silver nanoparticles.
@en
In vivo human time-exposure study of orally dosed commercial silver nanoparticles.
@nl
type
label
In vivo human time-exposure study of orally dosed commercial silver nanoparticles.
@en
In vivo human time-exposure study of orally dosed commercial silver nanoparticles.
@nl
prefLabel
In vivo human time-exposure study of orally dosed commercial silver nanoparticles.
@en
In vivo human time-exposure study of orally dosed commercial silver nanoparticles.
@nl
P2093
P2860
P1476
In vivo human time-exposure study of orally dosed commercial silver nanoparticles
@en
P2093
Cassandra E Deering-Rice
David W Grainger
Greg C Hadlock
Greg Stoddard
Jonathan Falconer
Mark A Munger
Przemyslaw Radwanski
P2860
P356
10.1016/J.NANO.2013.06.010
P577
2013-06-28T00:00:00Z